Skip to content
Lower risk Medical device recall · FDA · Published October 13, 2022

BD Phoenix PMIC/ID-107 Recall: False antibiotic resistance reports due to minocycline

Becton Dickinson recalls BD Phoenix PMIC/ID-107 panels that may cause false resistance reports in antibiotic tests, delaying treatment. Affected units have specific lot numbers and expiration dates.

🇺🇸 FDA recall #Z-0232-2023Medical deviceBecton Dickinson ›
Take action

Contact the company

Recalling firmBecton Dickinson & Co.7 Loveton Cir · Sparks, MD 21152-9212
✎ GovInfoNow plain-language explainer

Becton Dickinson is recalling BD Phoenix PMIC/ID-107 panels used in antibiotic testing. These panels can produce false resistance results for minocycline, potentially delaying proper antibiotic treatment if the Quality Control testing passes. Read more at govinfonow.com/recall/59918-bd-phoenix-pmic-id-107-recall-false-antibiotic-resistance-reports.

Source Summary by GovInfoNow · govinfonow.com/recall/59918-bd-phoenix-pmic-id-107-recall-false-antibiotic-resistance-reports · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0232-2023

Cite this page

“BD Phoenix PMIC/ID-107 Recall: False antibiotic resistance reports due to minocycline.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/59918-bd-phoenix-pmic-id-107-recall-false-antibiotic-resistance-reports. Based on FDA recall #Z-0232-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0232-2023%22&limit=1).

The FDA announced on Oct. 13, 2022, that Becton Dickinson & Co. is voluntarily recalling BD Phoenix PMIC/ID-107 panels due to misformulation risks. The hazard involves erroneously increased Minimal Inhibitory Concentration values for minocycline testing. Owners should contact the company for further instructions.

How to tell if you have it

  • BD Phoenix PMIC/ID-107
  • UPC: 30382904486076
  • Catalog Number: 448607
  • Lot Number: 1355046
  • Expiration Date: 31JAN2023

The hazard

The misformulated minocycline can cause erroneously increased Minimal Inhibitory Concentration values when performing antibiotic susceptibility testing against minocycline. This may result in the reporting of false resistance for clinical samples if initial Quality Control testing passes, potentially delaying appropriate patient treatment.

Context

GovInfoNow's records show Becton Dickinson & Co. has 43 other recalls on record since June 1, 2017. Recent brand recalls include the BD GasP: CO2 Pouch System recall on April 7, 2026, and the BD Kiestra Isolate Suspension Cuvette Array recall on Oct. 23, 2025. Other recent recalls of similar products include the Biomerieux VITEK 2 AST-N447 Kit Recall (June 4, 2026), the HardyDisk AST Cefiderocol 30μg FDC30 recall (June 8, 2026), and the Biomerieux VITEK 2 AST-N461 Test Kit Recall (July 24, 2026).

How to tell if you have this one

Check for the lot number 1355046 and expiration date 31JAN2023 on the panel. The product is sold under catalog number 448607 with specific UDI codes.

  • Brand
    Becton Dickinson
  • Product
    BD Phoenix PMIC/ID-107: The Phoenix PMIC/ID panel is used for the rapid identification and susceptibility of most
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Panel Details

    Look for lot number 1355046 and expiration date 31JAN2023 on the panel.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 41 days after the firm started it.

1. Firm started the recall: Oct 13, 202212. FDA classified it Class II: Nov 14, 202223. Published in FDA’s Enforcement Report: Nov 23, 202232022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0232-2023 (October 13, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0232-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA